Thomas Andrew Rowland - 12 Aug 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP, HEAD - ESTABLISHED BRANDS
Signature
/s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Aug 2025
Net transactions value
-$426,407
Form type
4
Filing time
14 Aug 2025, 17:53:08 UTC
Previous filing
04 Mar 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook 14 Aug 2025 0001507496

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $426,407 -4,975 -11% $85.71 40,794 12 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.
F2 Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).